Drug-Patent Linkage System

Drug-Patent Informatics

EXIA(prior to Klasia) had made and managed Drug-Patent Informatics website that currently operated by Ministry of Food and Drug Safety(http://medipatent.mfds.go.kr/)


Item Selection

1. Analysis of all trialed and untrialed market exclusivity items

The following summarizes the strategic approach of the patent. approval linkage. Klasia selects competitive items after analyzing all items in the Green List from MFDS(similar to the Orange Book)

Item Selection

2. Classification items

After selection of items, we have classified into the untrialed and market exclusivity one.

Finally, we classified the items into four categories and identified differentiated business items through strategic analysis.